Molecule Holdings Inc.
MLCL
CNSX
| 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 19.94% | 34.17% | 52.92% | -76.52% | 30.60% |
| Total Depreciation and Amortization | -3.22% | -6.28% | -4.41% | -5.75% | -7.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -138.14% | -9.70% |
| Total Other Non-Cash Items | 121.50% | 4,413.79% | -77.25% | 466.61% | -106.15% |
| Change in Net Operating Assets | 83.15% | -95.60% | 786.63% | 247.02% | 322.04% |
| Cash from Operations | 97.28% | 47.34% | 91.63% | 106.77% | 16.46% |
| Capital Expenditure | -- | -- | -- | 100.00% | -16.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -70.00% | 166.31% | -- | -99.46% | -97.60% |
| Total Debt Issued | -85.71% | 0.00% | -- | -75.49% | -75.25% |
| Total Debt Repaid | -1,698.10% | -1.27% | 0.00% | -1,582.28% | 1.25% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -493.23% | -30.46% |
| Cash from Financing | -569.25% | 58.82% | 81.13% | -106.32% | -96.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.11% | 2,916.39% | 91.36% | 137.68% | -121.50% |